employee
Was studied the relationship between the parameters of carbohydrate and lipid metabolism, body mass index, HOMA-IR index and leptin concentration in patients with diabetes mellitus type 2 diabetes mellitus with normal motor-evacuation function of the stomach and gastroparesis (groups 1 and 2), as well as a comparison group with functional dyspepsia (Group 3). In patients with a high leptin content of 52.34 ± 4.31 ng / ml, according to the results of gastric ultrasound, there were signs of diabetic gastroparesis, predominantly moderate and severe (64.3%). Analysis of factors affecting the concentration of leptin among the studied groups showed the relationship of this hormone with BMI, insulin resistance, HOMA-IR index, and lipid metabolism disorders. In patients with diabetes mellitus type 2 and a BMI above 30.0 kg / m2, there was a significant (p <0.05) gastric motility disorders and hyperleptinemia when compared with patients of the first group without gastroparesis, who showed a statistically insignificant (p> 0.05) increase in leptin. The results of this study indicate a high content of leptin in the blood serum of patients with diabetic gastroparesis associated with a slowdown in metabolism due to gastric motility disorders, carbohydrate and lipid metabolism disorders and is a reliable diagnostic marker of the development and progression of complications in patients with type 2 diabetes mellitus.
dyspepsia, gastroparesis, diabetes, leptin, triglycerides, insulin resistance
1. Camilleri M., Parkman H. P., Shafi M. A. Clinical guideline: management of gastroparesis. Am J Gastroenterol. 2013;108(1):18–37. doi:10.1038/ ajg.2012.373.
2. Diabetes UK. Diabetes prevalence 2016. Available at: https://www.diabetes.org.uk/ professionals/position-statements-reports/statistics/ diabetes-prevalence-2016. Accessed 7 June 2018.
3. Diabetes UK. Diabetes UK facts and stats 2016. Available at: https://diabetes-resources-production. s3-eu-west-1.amazonaws.com/diabetes-storage/ migration/pdf/DiabetesUK_Facts_Stats_Oct16.pdf. Accessed 7 June 2018.
4. American Diabetes Association. Improving care and promoting health in populations: standards of medical care in diabetes. 2018;41(Suppl 1):S7–S12. doi:10.2337/dc18-S001.
5. A mer ic an Di ab et es As s o ci a t ion. Comprehensive medical evaluation and assessment of comorbidities. 2018;41:S25–S32. doi:10.2337/ dc17-S006.
6. Bharucha A. E., Batey-Schaefer B., Cleary P. A. Delayed gastric emptying is associated with early and long-term hyperglycemia in Type 1 diabetes mellitus. Gastroenterology. 2015; 149:330–339. doi:10.1053/j. gastro.2015.05.007.
7. Anudeep V., Vinod K. V., Pandit N. Prevalence and predictors of delayed gastric emptying among Indian patients with long-standing type 2 diabetes mellitus. Indian J Gastroenterol. 2016;35:385–392. doi:10.1007/s12664-016-0694-4.
8. Koch K. L., Hasler W. L., Yates K. P. Baseline features and differences in 48 week clinical outcomes in patients with gastroparesis and type 1 vs type 2 diabetes. Neurogastroenterol Motil. 2016;28:1001–15. doi:10.1111/nmo.12800.
9. Singla R., Homko C., Schey R. Diabetes- related autoantibodies in diabetic gastroparesis. Dig Dis Sci. 2015;60:1733–37. doi:10.1007/s10620-015- 3690-0.
10. Wu S. P., DeMayo F. J. Progesterone receptor signaling in uterine myometrial physiology and preterm birth. Curr Top Dev Biol. 2017;125:171–190. doi:10.1016/bs.ctdb.2017.03.001.
11. Perano S. J., Rayner C. K., Kritas S. Gastric emptying is more rapid in adolescents with Type 1 diabetes and impacts on postprandial glycemia. J Clin Endocrinol Metab. 2015; 100:2248–53. doi:10.1210/ jc.2015-1055.
12. Phillips L. K., Deane A. M., Jones K. L. Gastric emptying and glycaemia in health and diabetes mellitus. Nat Rev Endocrinol. 2015;11:112–128. doi:10.1038/ nrendo.2014.202.
13. Marathe C. S., Horowitz M., Trahair L. G. Relationships of early and late glycemic responses with gastric emptying during an oral glucose tolerance test. J Clin Endocrinol Metab. 2015;100:3565–3571. doi:10.1210/JC.2015-2482.
14. Marathe C. S., Rayner C. K., Jones K. L. Novel insights into the effects of diabetes on gastric motility. Expert Rev Gastroenterol Hepatol. 2016;10:581–593. doi:10.1586/17474124.2016.1129898.
15. American Diabetes Association. Prevention or delay of type 2 diabetes: standards of medical care in diabetes—2018. Diabetes Care 2018;41(1):S51–S54. doi:10.2337/dc18-S005.
